Ingevity (NYSE:NGVT – Get Free Report) will likely be releasing its Q4 2025 results before the market opens on Tuesday, February 17th. Analysts expect Ingevity to post earnings of $0.74 per share for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 18, 2026 at 10:00 AM ET.
Ingevity Price Performance
NGVT opened at $72.61 on Tuesday. The company has a market capitalization of $2.61 billion, a price-to-earnings ratio of -39.89 and a beta of 1.34. The company has a current ratio of 1.27, a quick ratio of 0.80 and a debt-to-equity ratio of 8.39. Ingevity has a 12-month low of $28.49 and a 12-month high of $77.46. The business’s fifty day simple moving average is $62.52 and its 200-day simple moving average is $56.64.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on NGVT shares. BMO Capital Markets boosted their price target on shares of Ingevity from $64.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Wells Fargo & Company increased their target price on Ingevity from $60.00 to $65.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 28th. Zacks Research upgraded Ingevity to a “hold” rating in a report on Tuesday, December 16th. Wall Street Zen upgraded Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 3rd. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Ingevity has a consensus rating of “Hold” and a consensus target price of $67.50.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Millennium Management LLC grew its stake in shares of Ingevity by 1.3% during the third quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock worth $65,650,000 after acquiring an additional 15,562 shares during the last quarter. Maple Rock Capital Partners Inc. boosted its stake in Ingevity by 3.2% in the 3rd quarter. Maple Rock Capital Partners Inc. now owns 674,716 shares of the company’s stock worth $37,238,000 after purchasing an additional 21,200 shares in the last quarter. Simcoe Capital Management LLC increased its stake in Ingevity by 188.8% during the 2nd quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock valued at $26,928,000 after purchasing an additional 408,508 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after buying an additional 454,579 shares during the last quarter. Finally, Vision One Management Partners LP raised its holdings in shares of Ingevity by 0.9% in the third quarter. Vision One Management Partners LP now owns 457,817 shares of the company’s stock worth $25,267,000 after buying an additional 3,907 shares during the last quarter. 91.59% of the stock is owned by institutional investors and hedge funds.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Read More
- Five stocks we like better than Ingevity
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
